Brief Reports
Loss of bone mineral in patients with cachexia due to chronic heart failure

https://doi.org/10.1016/S0002-9149(98)00927-8Get rights and content

First page preview

First page preview
Click to open first page preview

References (19)

There are more references available in the full text version of this article.

Cited by (111)

  • Sarcopenia, osteoporosis and frailty

    2023, Metabolism: Clinical and Experimental
  • Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure

    2020, Heart Failure Clinics
    Citation Excerpt :

    Loss of myocardium may be one of the mechanisms explaining the intrinsic relationship between cachexia and decreased survival. Studies investigating loss of the third body compartment, that is, bone tissue, during cardiac cachexia are scarce and have yielded controversial findings so far.16,21 A number of chronic diseases other than HF can be complicated by the development of cachexia, the most important being cancer, chronic obstructive lung disease, chronic kidney disease, and rheumatoid arthritis.22

  • Metabolic impairment in heart failure: The myocardial and systemic perspective

    2014, Journal of the American College of Cardiology
    Citation Excerpt :

    Osteopenia and genuine osteoporosis beyond normal age-related associations have been observed in HF and advance with higher stages of the disease (41). Patients with severe HF and those with cachexia demonstrate pronounced loss of bone mass (42), although no direct associations with impaired left ventricular (LV) ejection fraction or peak VO2 were observed (43). In advanced HF, significant bone loss occurs frequently (in 30% of patients [44]) and as a component of overall tissue wasting (see later discussion).

View all citing articles on Scopus
View full text